| 7.31 Data as of 2:43pm ET |  -0.0272 / -0.37%Today’s Change | 2.85 Today|||52-Week Range 7.85 | +141.35% Year-to-Date |
| Previous close | 7.34 |
| Today’s open | 7.38 |
| Day’s range | 7.30 - 7.42 |
| Volume | 9,070 |
| Average volume (3 months) | 43,515 |
| Market cap | $186.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +63.96% |
| Earnings growth (this year) | -140.08% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -20.13% |
| P/E ratio | NM |
| Price/Sales | 2.92 |
| Price/Book | 6.12 |
| Today’s change | Today’s % change | |
|---|---|---|
| OCRXOcera Therapeutics I... | -0.51 | -4.16% |
| MEIPMEI Pharma Inc | -0.26 | -3.06% |
| NWBONorthwest Biotherape... | -0.22 | -5.33% |
| DSCODiscovery Laboratori... | -0.05 | -2.29% |
| Next reporting date | March 5, 2014 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $26.1M |
| Annual profit (last year) | -$3.2M |
| Net profit margin | -12.37% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Investor Relations Contact Stephen H. Willard |
Chief Executive Officer & Director Michael Shannon Anderson |
Corporate headquarters Vénissieux, Rhone-alpes |
.
